ULTRA-PROCESSED FOODS AND CARDIOMETABOLIC RISK: FROM EVIDENCE TO POLICY

Descargar Publicación
Berobenatida: el GLP-1 mensual de Pfizer Diversity in metabolic dysfunction-associated steatotic liver disease: a framework for precision medicine